Finepoint Capital LP Q2 2023 Filing

Filed August 11, 2023

Portfolio Value

$289.1B

Holdings

37

Report Date

Q2 2023

Filing Type

13F-HR

All Holdings (37 positions)

#StockSharesValue% PortfolioType
1
APLSAPELLIS PHARMACEUTICALS INC
241,690$22K0.00%
2
PRTAPROTHENA CORP PLC
317,300$21K0.00%
3
ACADACADIA PHARMACEUTICALS INC
846,953$20K0.00%
4
GLPGGALAPAGOS NV
406,859$16K0.00%
5
MORFMORPHIC HOLDING INC
287,556$16K0.00%
6
SG7SAGE THERAPEUTICS INC
357,765$16K0.00%
7
AM6AMICUS THERAPEUTICS INC
1,325,775$16K0.00%
8
SWTXSPRINGWORKS THERAPEUTICS INC
608,628$15K0.00%
9
CERE1EURCEREVEL THERAPEUTICS HLDNG I
492,545$15K0.00%
10
MLTXMOONLAKE IMMUNOTHERAPEUTICS
302,000$15K0.00%
11
CRNXCRINETICS PHARMACEUTICALS IN
797,527$14K0.00%
12
SRPTSAREPTA THERAPEUTICS INC
125,457$14K0.00%
13
ASNDASCENDIS PHARMA A/S
139,772$12K0.00%
14
CYTKCYTOKINETICS INC
369,093$12K0.00%
15
TVTXTRAVERE THERAPEUTICS INC
761,721$11K0.00%
16
CLVTCLARIVATE PLC
1,247,406$11K0.00%
17
ARVNARVINAS INC
411,500$10K0.00%
18
BHCBAUSCH HEALTH COS INC
1,165,000$9K0.00%
19
RLAYRELAY THERAPEUTICS INC
701,570$8K0.00%
20
SLDBSOLID BIOSCIENCES INC
961,251$5K0.00%
21
HOME PLATE ACQUISITION CORP
690,000$00.00%
22
CNDAWCONCORD ACQUISITION CORP II
408,333$00.00%
23
AFTERNEXT HEALTHTECH ACQUISITION CORP
366,666$00.00%
24
YS BIOPHARMA CO LTD
489,999$00.00%
25
CCIXCHURCHILL CAPITAL CORP VI
540,000$00.00%
26
ROSS ACQUISITION CORP II
439,666$00.00%
27
CCIXCHURCHILL CAPITAL CORP V
612,000$00.00%
28
CORSAIR PARTNERING CORP
334,666$00.00%
29
BRIDGETOWN HOLDINGS LTD
895,000$00.00%
30
CONYERS PARK III ACQUISITION CORP
571,666$00.00%
31
CCIXCHURCHILL CAPITAL CORP VII
548,000$00.00%
32
CLDWWFIRST LIGHT ACQUISITION GROUP INC
655,200$00.00%
33
SWIFTMERGE ACQUISITION CORP
490,000$00.00%
34
ARES ACQUISITION CORP
504,706$00.00%
35
CDAQFCOMPASS DIGITAL ACQUISITION CORP
459,906$00.00%
36
MARBLEGATE ACQUISITION CORP
735,000$00.00%
37
BILANDER ACQUISITION CORP
183,749$00.00%